Onbrez Breezhaler From Novartis Provides Greater Clinical Benefits Than Tiotropium in New Study of COPD Patients - Drugs.com MedNews
Links shared publicly online about this topic.
- 754total visits
Onbrez Breezhaler From Novartis Provides Greater Clinical Benefits Than Tiotropium in New Study of COPD Patients - Drugs.com MedNews
Study shows Onbrez Breezhaler superior to tiotropium in reducing breathlessness and use of rescue medication and in improving overall health status 1 INTENSITY
View full resource at drugs.com
Tags: COPD, COPD Medication, Drug, Healthy Living, Spiriva, Novartis
Most Recently Shared on November 3, 2010 at 3:09 pm By:
Onbrez Breezhaler From Novartis Provides Greater Clinical Benefits Than Tiotropium in New Study of COPD Patie... http://bit.ly/ab5rWP #drug
Onbrez Breezhaler from Novartis provides greater clinical benefits than tiotropium in new study of COPD patients
novartis.com — “Onbrez Breezhaler from Novartis provides greater clinical benefits than tiotropium in new study of COPD patients” View full resource at novartis.com
Most Recently Shared on November 3, 2010 at 6:22 am By:
INTENSITY study from Novartis presented at #CHEST10 provides new H2H data comparing two COPD drugs http://bit.ly/cN61nM
Advertisement
